Financial Framework (Supplementary Powers) Amendment (Health Measures No. 4) Regulations 2018 (Cth)

Financial Framework (Supplementary Powers) Amendment (Health Measures No. 4) Regulations 2018

I, General the Honourable Sir Peter Cosgrove AK MC (Ret’d), Governor‑General of the Commonwealth of Australia, acting with the advice of the Federal Executive Council, make the following regulations.

Dated 11 October 2018

Peter Cosgrove

Governor‑General

By His Excellency’s Command

Mathias Cormann

Minister for Finance and the Public Service

Contents

1Name

This instrument is the Financial Framework (Supplementary Powers) Amendment (Health Measures No. 4) Regulations 2018.

2Commencement

(1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

Commencement information
Column 1	Column 2	Column 3
Provisions	Commencement	Date/Details
1. The whole of this instrument	The day after this instrument is registered.	13 October 2018

Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

(2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3Authority

This instrument is made under the Financial Framework (Supplementary Powers) Act 1997.

4Schedules

Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.

Schedule 1—Amendments

Financial Framework (Supplementary Powers) Regulations 1997

1. 1

   In the appropriate position in Part 4 of Schedule 1AB (table)

Insert:

305	National Return of Unwanted Medicines Program	To provide funding for a national collection and disposal service to consumers for expired or unwanted medicines, including: (a) to coordinate the collection, and subsequent transport and disposal, of returned medicines from community pharmacies; and (b) to ensure the proper and safe disposal of medicines; and (c) to increase awareness amongst consumers, pharmacists and other health professionals regarding the availability of the service. This objective also has the effect it would have if it were limited to measures: (a) providing, or incidental to the provision of, pharmaceutical benefits, sickness benefits or medical services; or (b) to give effect to Australia’s obligations under the International Covenant on Economic, Social and Cultural Rights, particularly Articles 2 and 12.
306	Quality use of Diagnostics, Therapeutics and Pathology Program	To provide funding toNPS MedicineWise to improve the way in which health technologies, medicines and medical tests are prescribed and used, including: (a) to develop and deliver educational materials on the appropriate use of medicines; and (b) to provide appropriate healthcare interventions to promote the appropriate use of subsidised diagnostics, therapeutics and pathology; and (c) to promote free access to information about the judicious and safe use of diagnostics, therapeutics and pathology; and (d) to develop and provide tools and resources aimed at ensuring the appropriate, safe and efficacious use of medicines and health technologies. This objective also has the effect it would have if it were limited to measures: (a) providing, or incidental to the provision of, pharmaceutical benefits, sickness benefits or medical services; or (b) to give effect to Australia’s obligations under the International Covenant on Economic, Social and Cultural Rights, particularly Articles 2 and 12.
307	Value in Prescribing Program	To provide funding to entities to deliver healthcare interventions aimed at promoting the appropriate use of medicines and blood products, including: (a) to develop and deliver educational materials on the appropriate use of Pharmaceutical Benefits Scheme (PBS) items, medicines and blood products; and (b) to develop and provide training on decision support tools aimed at supporting the efficient and appropriate use of PBS items, medicines and blood products; and (c) to support the professional development of specialist healthcare providers in relation to the prescription and appropriate use of PBS items, medicines and blood products; and (d) to increase the delivery to consumers and pharmacists of information and educational activities relating to the appropriate use of PBS medicines and blood products. This objective also has the effect it would have if it were limited to measures: (a) providing, or incidental to the provision of, pharmaceutical benefits, sickness benefits or medical services; or (b) to give effect to Australia’s obligations under the International Covenant on Economic, Social and Cultural Rights, particularly Articles 2 and 12.